EP14.04. BRCA-Associated Protein-1 (BAP1) Loss and Real-World Outcomes of Immune Checkpoint Inhibitor Therapy in Pleural Mesothelioma - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Caleb Smith
Meta Tag
Speaker Caleb Smith
Topic Mesothelioma, Thymoma & Other Thoracic Tumors: Clinical
immune checkpoint inhibitor therapy
pleural mesothelioma
BAP1 status
therapy response
ipilimumab plus nivolumab
tumor suppressor gene
immunotherapy regimen
progression-free survival
overall survival
predictive markers
Powered By